September 22, 2017 3:13 AM ET

Pharmaceuticals

Company Overview of Tacere Therapeutics, Inc.

Key Executives for Tacere Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Sara M. Hall 3 RelationshipsCo-Founder, Chief Executive Officer and Director--
Linda B. Couto Ph.D.No RelationshipsVice President of Research & Development--

Tacere Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Sara M. Hall 3 RelationshipsTacere Therapeutics, Inc.--
John Monahan Ph.D. 40 RelationshipsSynthetic Biologics, Inc.71
Curtis L. Scribner M.D., MBA 3 RelationshipsAmarantus Bioscience Holdings, Inc66
Yasuo Urata M.Sc. 11 RelationshipsOncolys BioPharma Inc.62
View All Board Members

Tacere Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
404.9K
Bonus
417.3K
Total Short Term Compensation
566.6K
Total Value of Options
8.0M
Compensation as of Fiscal Year
Tacere Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Alastair McEwan Steps Down as Chief Operating Officer of Veloxis Pharmaceuticals A/S
September 20, 2017 9:03 PM ET
Sucampo Pharmaceuticals, Inc. Announces Appointment of Alex Driggs to General Counsel and Corporate Secretary
September 20, 2017 8:15 PM ET
DURECT Corporation Appoints Myriam Theeuwes as Senior Vice President, Clinical Development
September 20, 2017 12:00 PM ET
Kilitch Drugs (India) Limited Announces Executive Changes
September 20, 2017 11:47 AM ET
Mallinckrodt Pharmaceuticals Announces the Election of David Norton to the Company's Board of Directors
September 20, 2017 10:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tacere Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.